University of Ottawa Heart Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Can J Cardiol. 2020 Apr;36(4):564-576. doi: 10.1016/j.cjca.2019.09.019. Epub 2019 Oct 3.
Myocardial infarction and heart failure are associated with reduced voltage-gated Na current (I) that promotes arrhythmias and sudden deaths. We have previously shown that the Wnt/β-catenin signalling (Wnt signalling), which is active in heart disease, reduces cardiac I, suggesting that Wnt signalling may be a potential therapeutic target. However, because Wnt signalling is required for the homeostasis of many noncardiac tissues, administration of Wnt inhibitors to heart patients would cause significant side effects. The present study aims to elucidate the molecular mechanisms of cardiac I inhibition by Wnt, which would identify cardiac-specific therapeutic targets.
Wnt signalling was activated in neonatal rat ventricular myocytes by Wnt3a protein. Adenovirus expressing Wnt3a was injected into the adult rat ventricle. CRISPR/Cas9 and chromatin immunoprecipitation were used for mechanistic studies.
Wnt signalling activation in neonatal rat ventricular myocytes reduced Na1.5 protein and Scn5a mRNA, but increased Tbx3, a known suppressor of Scn5a. Chromatin immunoprecipitation showed that Wnt signalling inhibits Scn5a expression through downstream mediator (TCF4) binding to both Tbx3 and Scn5a promoters. Overexpression or knockdown of Tbx3 directly modified Na1.5 and I, whereas CRISPR/Cas9-induced mutations at TCF4 binding sites within the Scn5a promoter attenuated Wnt inhibition of Scn5a and Na1.5. In adult rat hearts, adenovirus expressing Wnt3a reduced Na1.5, increased QRS duration in electrocardiogram, and increased the susceptibility to ventricular tachycardia.
Wnt signalling inhibits the Na channel by direct and indirect (via Tbx3) suppression of Scn5a transcription. Strategies to block TCF4 binding to the Tbx3 and Scn5a promoters would represent novel strategies for cardiac-specific inhibition of the Wnt pathway to rescue I and prevent sudden cardiac deaths.
心肌梗死和心力衰竭与电压门控钠电流(I)减少有关,这种电流会促进心律失常和猝死。我们之前已经表明,在心脏病中活跃的 Wnt/β-catenin 信号(Wnt 信号)会降低心脏 I,这表明 Wnt 信号可能是一个潜在的治疗靶点。然而,由于 Wnt 信号对于许多非心脏组织的内稳态是必需的,因此向心脏病患者施用 Wnt 抑制剂会引起严重的副作用。本研究旨在阐明 Wnt 抑制心脏 I 的分子机制,这将确定心脏特异性治疗靶点。
用 Wnt3a 蛋白激活新生大鼠心室肌细胞中的 Wnt 信号。将表达 Wnt3a 的腺病毒注射到成年大鼠心室中。使用 CRISPR/Cas9 和染色质免疫沉淀进行机制研究。
新生大鼠心室肌细胞中 Wnt 信号的激活减少了 Na1.5 蛋白和 Scn5a mRNA,但增加了 Tbx3,Tbx3 是 Scn5a 的已知抑制剂。染色质免疫沉淀表明,Wnt 信号通过下游介质(TCF4)与 Tbx3 和 Scn5a 启动子结合来抑制 Scn5a 表达。Tbx3 的过表达或敲低直接改变了 Na1.5 和 I,而 CRISPR/Cas9 诱导的 Scn5a 启动子中 TCF4 结合位点的突变减弱了 Wnt 对 Scn5a 和 Na1.5 的抑制作用。在成年大鼠心脏中,表达 Wnt3a 的腺病毒减少了 Na1.5,增加了心电图的 QRS 持续时间,并增加了室性心动过速的易感性。
Wnt 信号通过直接和间接(通过 Tbx3)抑制 Scn5a 转录来抑制钠通道。阻止 TCF4 与 Tbx3 和 Scn5a 启动子结合的策略将代表心脏特异性抑制 Wnt 途径以挽救 I 和预防心脏性猝死的新策略。